Gregory Lip

Regional Differences in Antithrombotic Treatment for Atrial Fibrillation: Insights from the GLORIA-AF Phase II Registry

Michał Mazurek, Menno V. Huisman, Kenneth Rothman et al. · Thrombosis and Haemostasis · 2017 · 102 citations · Full text

Antithrombotic Treatment, Pharmacotherapy, Thrombosis +23

How European centres diagnose, treat, and prevent CIED infections: Results of an European Heart Rhythm Association survey

Maria Grazia Bongiorni, Germanas Marinskis, Gregory Lip et al. · EP Europace · 2012 · 66 citations · Full text

Lead Extraction Guidelines, Prevent Cied Infections, European Centres +18

Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the Association for Acute CardioVascular Care and the Asia-Pacific Heart Rhythm Society

Diana A. Gorog, Ying X. Gue, Tze‐Fan Chao et al. · EP Europace · 2022 · 60 citations · Full text

Cardioversion for atrial fibrillation in current European practice: results of the European Heart Rhythm Association survey

Antonio Hernández‐Madrid, Jesper Hastrup Svendsen, Gregory Lip et al. · EP Europace · 2013 · 49 citations · Full text

Heart Failure, Cardiac Anaesthesia, Cardiovascular Pharmacology +21

A pilot study of homocyst(e)ine levels in essential hypertension: relationship to von willebrand factor, an index of endothelial damage

Gregory Lip · American Journal of Hypertension · 2001 · 46 citations · Full text